• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

New Global Head of Development for Daiichi Sankyo

Article

September 7, 2016

Daiichi Sankyo, Inc. (Edison,NJ) announced the appointment of Marielle Cohard-Radice, M.D., as Executive Vice President, Global Head of Development.

In her new role, Dr. Cohard-Radice will have responsibility for the development strategy and portfolio planning for the Cardiovascular-Metabolism and Internal Medicine therapeutic areas.

Prior to her promotion, Marielle Cohard-Radice was Vice President of Clinical Development Operations at Daiichi Sankyo Pharma Development, a position she held since 2012. 

The former Global Head of Development, Mahmoud Ghazzi, M.D., Ph.D, has decided to leave the company.

Related Videos